This binding impedes the interaction of hnRNPK with MYC DNA and MYC mRNA, consequently inhibiting MYC transcription and translation, thereby playing a role in the progression of lung small cell carcinoma (NSCLC) via the hnRNPK-MYC-CDC25A pathway [17]. The gene discussed is HNRNPK; the disease is non-small cell lung carcinoma.